1. Home
  2. SLDB vs WBX Comparison

SLDB vs WBX Comparison

Compare SLDB & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • WBX
  • Stock Information
  • Founded
  • SLDB 2013
  • WBX 2015
  • Country
  • SLDB United States
  • WBX Spain
  • Employees
  • SLDB N/A
  • WBX N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • WBX Industrial Specialties
  • Sector
  • SLDB Health Care
  • WBX Consumer Discretionary
  • Exchange
  • SLDB Nasdaq
  • WBX Nasdaq
  • Market Cap
  • SLDB 124.7M
  • WBX 119.6M
  • IPO Year
  • SLDB 2018
  • WBX N/A
  • Fundamental
  • Price
  • SLDB $5.78
  • WBX $0.51
  • Analyst Decision
  • SLDB Strong Buy
  • WBX Buy
  • Analyst Count
  • SLDB 12
  • WBX 3
  • Target Price
  • SLDB $17.83
  • WBX $1.17
  • AVG Volume (30 Days)
  • SLDB 5.4M
  • WBX 331.8K
  • Earning Date
  • SLDB 03-12-2025
  • WBX 02-26-2025
  • Dividend Yield
  • SLDB N/A
  • WBX N/A
  • EPS Growth
  • SLDB N/A
  • WBX N/A
  • EPS
  • SLDB N/A
  • WBX N/A
  • Revenue
  • SLDB N/A
  • WBX $179,622,844.00
  • Revenue This Year
  • SLDB N/A
  • WBX $18.23
  • Revenue Next Year
  • SLDB N/A
  • WBX $21.57
  • P/E Ratio
  • SLDB N/A
  • WBX N/A
  • Revenue Growth
  • SLDB N/A
  • WBX 16.10
  • 52 Week Low
  • SLDB $2.88
  • WBX $0.41
  • 52 Week High
  • SLDB $15.05
  • WBX $1.73
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 69.94
  • WBX 49.90
  • Support Level
  • SLDB $3.15
  • WBX $0.45
  • Resistance Level
  • SLDB $7.20
  • WBX $0.62
  • Average True Range (ATR)
  • SLDB 0.63
  • WBX 0.04
  • MACD
  • SLDB 0.37
  • WBX 0.01
  • Stochastic Oscillator
  • SLDB 67.13
  • WBX 37.43

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

Share on Social Networks: